Redeye updates on EG7 after Q1-results where sales came in above expectations while EBITDA was somewhat soft. While we trim estimates, we continue to see topline and earnings growth potential in coming quarters, supported by new game releases (Palia and the Cold Iron game project) coupled with cost savings and M&A optionality.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/